TEVA PHARMACEUTICAL INDUSTRIES LIMITED Derivative Asset, Fair Value, Gross Asset
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Derivative Asset, Fair Value, Gross Asset of $59.00 million as of 2011-09-30, per its 6-K filed 2011-11-02.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeAsset · last filed 2011-11-02
- 2011-09-30: Derivative Asset, Fair Value, Gross Asset $59.00M.
- 2011-06-30: Derivative Asset, Fair Value, Gross Asset $33.00M.
- 2011-03-31: Derivative Asset, Fair Value, Gross Asset $45.00M.
- 2010-12-31: Derivative Asset, Fair Value, Gross Asset $17.00M.
| Period end | Derivative Asset, Fair Value, Gross Asset |
|---|---|
| 2011-09-30 | $59.00M 6-K · filed 2011-11-02 |
| 2011-06-30 | $33.00M 6-K · filed 2011-07-28 |
| 2011-03-31 | $45.00M 6-K · filed 2011-05-11 |
| 2010-12-31 | $17.00M 6-K · filed 2011-11-02 |
| 2010-09-30 | $81.00M 6-K · filed 2010-11-02 |
| 2010-06-30 | $11.00M 6-K · filed 2010-07-27 |
| 2010-03-31 | $17.00M 6-K · filed 2011-05-11 |
| 2009-12-31 | $20.00M 20-F · filed 2011-02-15 |